STOCK TITAN

Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced that President and CEO Chris Simon will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2023, at 2:15 PM Pacific time. The live presentation will be available via audio webcast, accessible through Haemonetics' Investor Relations website. A replay will be available for 30 days after the event. Haemonetics focuses on innovative medical solutions aimed at improving patient care and reducing healthcare costs, specifically in blood and plasma component collection.

Positive
  • None.
Negative
  • None.

BOSTON, Dec. 19, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 10, 2023 at 2:15pm Pacific time.

The public may access Mr. Simon's presentation live via audio webcast at: https://jpmorgan.metameetings.net/events/healthcare23/sessions/43838-haemonetics-corporation/webcast?gpu_only=true&kiosk=true 

The live webcast can also be accessed under the Events & Presentations section of the Company's Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Investor Relations website shortly after the live event.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:


Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com             



Media Contact:


Josh Gitelson, Director-Global Communications


(781) 356-9776


josh.gitelson@haemonetics.com


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-41st-annual-jp-morgan-healthcare-conference-301706487.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics' presentation at the J.P. Morgan Healthcare Conference?

Haemonetics will present on January 10, 2023, at 2:15 PM Pacific time.

Where can I watch the Haemonetics presentation live?

The presentation can be accessed via audio webcast at Haemonetics' Investor Relations website.

What is the focus of Haemonetics as a healthcare company?

Haemonetics is dedicated to medical solutions for blood and plasma collection, surgical suites, and hospital transfusion services.

How long will the replay of Haemonetics' presentation be available?

The replay will be available for 30 days after the live presentation.

Who is the CEO of Haemonetics presenting at the conference?

Chris Simon, President and CEO of Haemonetics, will present at the conference.

Haemonetics Corporation

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Stock Data

3.85B
49.75M
0.89%
113.68%
9.12%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
BOSTON